ATLASEnanta Pharmaceuticals (ENTA) earnings date: Nov 16, 2026
Enanta Pharmaceuticals (ENTA) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 16, 2026 (confirmed), after the close. Analysts expect EPS of -$0.82. Free email alerts for this report are just below.
Source: company filings and exchange data · Updated Nov 3, 2026
ATLAS view on ENTA
| Last price | $10.69 (+2.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.1% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Enanta Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Get an email before and after Enanta Pharmaceuticals reports, free with your ATLAS account
Earnings alerts are a free benefit of your ATLAS account. The company goes to your watchlist and we email you when it reports. Google signup is one click.
Create free accountENTA earnings at a glance
| Next report (confirmed) | Mon, Nov 16, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.82 |
| Last report | Aug 10, 2026 · Miss |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | -7.2% |
| Average move around a report | ±3.9% (last 5) |
| Sector | Healthcare · Biotechnology |
Enanta Pharmaceuticals earnings history: last 5 reports
Enanta Pharmaceuticals last reported on Aug 10, 2026: EPS of -$0.67 against an estimate of -$0.53 (-26.4% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 10, 2026 | -$0.53 | -$0.67 | -26.4% | Miss | -1.8% |
| May 27, 2026 | $2.91 | $2.90 | -0.3% | In line | -2.2% |
| May 11, 2026 | -$0.57 | -$0.45 | +21.1% | Beat | -5.3% |
| May 4, 2026 | $0.78 | $0.87 | +11.5% | Beat | +0.9% |
| Feb 23, 2026 | $1.01 | $0.59 | -41.6% | Miss | +9.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ENTA
See the fair value, the probability range and the earnings history of Enanta Pharmaceuticals on its ATLAS page.
Enanta Pharmaceuticals (ENTA) stock analysisPlans from €3.99 a month.
Enanta Pharmaceuticals earnings: frequently asked questions
When does Enanta Pharmaceuticals (ENTA) report earnings?
Enanta Pharmaceuticals is scheduled to report on Monday, November 16, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for ENTA?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.82 per share (USD). Estimates can change before the report.
How often does ENTA beat earnings estimates?
Of its last 5 reports with a recorded result, Enanta Pharmaceuticals beat the EPS estimate 2 times; the average surprise was -7.2%. Past results do not predict the next one.
How much does ENTA move around earnings?
Over its last 5 reports the stock moved an average of 3.9% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Enanta Pharmaceuticals beat earnings estimates last quarter?
Enanta Pharmaceuticals last reported on Aug 10, 2026: EPS of -$0.67 against an estimate of -$0.53 (-26.4% surprise), a miss.
How much does ENTA usually move in a day?
On a normal trading day the ATLAS model puts ENTA’s one-day range at about ±3.1%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 16, 2026
Educational information, not investment advice. Disclaimer